These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23919214)

  • 1. Inflammatory bowel disease: An archetype disorder of outer environment sensor systems.
    Actis GC; Rosina F
    World J Gastrointest Pharmacol Ther; 2013 Aug; 4(3):41-6. PubMed ID: 23919214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel diseases: Current problems and future tasks.
    Actis GC; Pellicano R; Rosina F
    World J Gastrointest Pharmacol Ther; 2014 Aug; 5(3):169-74. PubMed ID: 25133045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathologic galaxy modulating the genotype and phenotype of inflammatory bowel disease: comorbidity, contiguity, and genetic and epigenetic factors.
    Actis GC; Pellicano R
    Minerva Med; 2016 Dec; 107(6):401-412. PubMed ID: 27314869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
    Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
    Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
    [No Abstract]   [Full Text] [Related]  

  • 6. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and the pathogenesis of inflammatory bowel disease.
    Karlinger K; Györke T; Makö E; Mester A; Tarján Z
    Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
    Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
    World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?
    De Francesco MA; Caruso A
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into the genetics of inflammatory bowel disease.
    Cho JH; Brant SR
    Gastroenterology; 2011 May; 140(6):1704-12. PubMed ID: 21530736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
    Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
    Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.
    Leitner GC; Vogelsang H
    World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):5-20. PubMed ID: 26855808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.